US 12,459,937 B2
Fused imidazole derivative, preparation method therefor, and medical use thereof
Fanglong Yang, Shanghai (CN); Ling Zhang, Shanghai (CN); Liangliang Zheng, Shanghai (CN); Feng He, Shanghai (CN); and Weikang Tao, Shanghai (CN)
Assigned to Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu (CN)
Filed by Jiangsu Hengrui Pharmaceuticals Co., Ltd., Jiangsu (CN)
Filed on Mar. 26, 2025, as Appl. No. 19/091,638.
Application 19/012,024 is a division of application No. 18/043,508, granted, now 12,227,499, issued on Feb. 18, 2025, previously published as PCT/CN2021/115915, filed on Sep. 1, 2021.
Application 19/091,638 is a continuation of application No. 19/012,024, filed on Jan. 7, 2025.
Claims priority of application No. 202010905693.4 (CN), filed on Sep. 1, 2020; application No. 202010984336.1 (CN), filed on Sep. 18, 2020; application No. 202011124085.6 (CN), filed on Oct. 20, 2020; application No. 202011253077.1 (CN), filed on Nov. 11, 2020; application No. 202011407911.8 (CN), filed on Dec. 4, 2020; and application No. 202011627733.X (CN), filed on Dec. 31, 2020.
Prior Publication US 2025/0243195 A1, Jul. 31, 2025
This patent is subject to a terminal disclaimer.
Int. Cl. C07D 417/14 (2006.01); A61P 1/16 (2006.01); C07D 405/14 (2006.01); C07D 471/04 (2006.01); C07D 495/04 (2006.01)
CPC C07D 417/14 (2013.01) [A61P 1/16 (2018.01); C07D 405/14 (2013.01); C07D 471/04 (2013.01); C07D 495/04 (2013.01)] 20 Claims
 
1. A compound selected from the group consisting of:

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof.